BR0308747A - Gordura que compreende uma mistura de triglicerìdeos, processo apropriado para preparação da gordura de triglicerìdeo, processo de preparação de espalhante em emulsão de água em óleo comestìvel e espalhante - Google Patents

Gordura que compreende uma mistura de triglicerìdeos, processo apropriado para preparação da gordura de triglicerìdeo, processo de preparação de espalhante em emulsão de água em óleo comestìvel e espalhante

Info

Publication number
BR0308747A
BR0308747A BR0308747-6A BR0308747A BR0308747A BR 0308747 A BR0308747 A BR 0308747A BR 0308747 A BR0308747 A BR 0308747A BR 0308747 A BR0308747 A BR 0308747A
Authority
BR
Brazil
Prior art keywords
fat
triglycerides
acid residues
fatty acid
carbon atoms
Prior art date
Application number
BR0308747-6A
Other languages
English (en)
Other versions
BR0308747B1 (pt
Inventor
Eckhard Floeter
Original Assignee
Unilever Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Unilever Nv filed Critical Unilever Nv
Publication of BR0308747A publication Critical patent/BR0308747A/pt
Publication of BR0308747B1 publication Critical patent/BR0308747B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
    • A23D7/001—Spread compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS OR COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings or cooking oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/555—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells
    • A61K47/557—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound pre-targeting systems involving an organic compound, other than a peptide, protein or antibody, for targeting specific cells the modifying agent being biotin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/66—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells
    • A61K47/665—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid the modifying agent being a pre-targeting system involving a peptide or protein for targeting specific cells the pre-targeting system, clearing therapy or rescue therapy involving biotin-(strept) avidin systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6891—Pre-targeting systems involving an antibody for targeting specific cells
    • A61K47/6897—Pre-targeting systems with two or three steps using antibody conjugates; Ligand-antiligand therapies
    • A61K47/6898—Pre-targeting systems with two or three steps using antibody conjugates; Ligand-antiligand therapies using avidin- or biotin-conjugated antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/04—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fats or fatty oils
    • C11C3/10—Ester interchange
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • C12N15/877—Techniques for producing new mammalian cloned embryos
    • C12N15/8775—Murine embryos
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0006—Modification of the membrane of cells, e.g. cell decoration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0604—Whole embryos; Culture medium therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Plant Pathology (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)

Abstract

"GORDURA QUE COMPREENDE UMA MISTURA DE TRIGLICERìDEOS, PROCESSO APROPRIADO PARA PREPARAçãO DA GORDURA DE TRIGLICERìDEO, PROCESSO DE PREPARAçãO DE ESPALHANTE EM EMULSãO DE áGUA EM óLEO COMESTìVEL E ESPALHANTE". Gordura apropriada como fase graxa para a fabricação de espalhantes com baixo teor de gordura que são estáveis sob temperaturas ambiente elevadas, em que a gordura compreende uma mistura de triglicerídeos, na qual 2,5 a 5,5% em peso dos triglicerídeos são HHH triglicerídeos, 25 a 65% em peso, preferencialmente 25 a 55% em peso dos HHH triglicerídeos são triiglicerídeos monoácidos e os HHH triglicerídeos restantes são compostos de resíduos de ácidos graxos misturados, 1,5 a 5% em peso dos triiglicerídeos são HHM e HMH triglicerídeos, pelo menos 85% em peso dos resíduos de ácidos graxos H em HHM e HMH são resíduos de ácido palmítico, em que H indica resíduos de ácidos graxos saturados que possuem comprimentos de cadeia de mais de quinze átomos de carbono e M indica resíduos de ácidos graxos saturados que possuem comprimentos de cadeia de doze ou quatorze átomos de carbono e em que o resíduo M é colocado no meio ou em uma das posições terminais. Essa fase graxa pode ser obtida através da incorporação em óleo de triglicerídeo de gordura A e gordura B em que a gordura A e a gordura B juntas representam de 6 a 15% em peso da gordura e a razão em peso A/B encontra-se na faixa de 1/9 a 4/6, caracterizada pelo fato de que, na gordura A, pelo menos 50% em peso dos triglicerídeos são completamente saturados, pelo menos 80% em peso dos resíduos de ácidos graxos saturados componentes possuem comprimento de cadeia de dezesseis átomos de carbono (P) ou dezoito átomos de carbono (S), em que a razão P:S encontra-se na faixa de 75:25 a 25:75, até 5% em peso dos resíduos de ácidos graxos saturados possuem comprimento de cadeia de doze ou quatorze átomos de carbono e, na gordura B, pelo menos 20% em peso, preferencialmente pelo menos 25% em peso dos triglicerídeos consistem de HHM e HMH triglicerídeos.
BRPI0308747-6B1A 2002-04-09 2003-03-10 Gordura, seu processo de preparação, processo para a preparação de espalhante e espalhante BR0308747B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02076376 2002-04-09
PCT/EP2003/002625 WO2003084337A1 (en) 2002-04-09 2003-03-10 Triglyceride fat

Publications (2)

Publication Number Publication Date
BR0308747A true BR0308747A (pt) 2005-01-11
BR0308747B1 BR0308747B1 (pt) 2013-12-17

Family

ID=28685931

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0308747-6B1A BR0308747B1 (pt) 2002-04-09 2003-03-10 Gordura, seu processo de preparação, processo para a preparação de espalhante e espalhante

Country Status (12)

Country Link
US (1) US7524524B2 (pt)
EP (1) EP1492410B1 (pt)
AT (1) ATE457649T1 (pt)
AU (1) AU2003218752B2 (pt)
BR (1) BR0308747B1 (pt)
CA (1) CA2481700C (pt)
DE (1) DE60331298D1 (pt)
MX (1) MXPA04009732A (pt)
PL (1) PL205287B1 (pt)
RU (1) RU2307517C2 (pt)
WO (1) WO2003084337A1 (pt)
ZA (1) ZA200407149B (pt)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6388113B1 (en) 1999-06-04 2002-05-14 Consejo Superior De Investigaciones Cientificas ( Csic) High oleic/high stearic sunflower oils
MXPA05001630A (es) * 2002-08-12 2005-04-25 Unilever Nv Grasa de trigliceridos.
ATE509692T1 (de) 2003-07-17 2011-06-15 Unilever Nv Verfahren zur herstellung einer öl und strukturierungsmittel enthaltenden essbaren dispersion
GB0409156D0 (en) * 2004-04-24 2004-05-26 Haye Pierre A procedure to manufacture a texturized, thermo-resistant and thermo-irreversible gel composed of vegetable and/or animal fats and the product made with this
PL2266413T3 (pl) * 2005-01-28 2015-12-31 Unilever Bcs Europe Bv Jadalne dyspersje zawierające olej i środek nadający strukturę
WO2006087090A1 (en) 2005-02-17 2006-08-24 Unilever N.V. Granules comprising sterol
WO2007039020A1 (en) * 2005-09-26 2007-04-12 Unilever N.V. Non-hydrogenated hardstock fat
US8431177B2 (en) * 2007-08-02 2013-04-30 Bunge Oils, Inc. Shortenings and methods of making and using thereof
ATE553655T1 (de) * 2008-01-10 2012-05-15 Team Foods Colombia Sa Festes, trans-fettsäurefreies fettprodukt mit niedrigem gehalt an gesättigten fetten
WO2009152150A1 (en) * 2008-06-11 2009-12-17 General Mills Marketing, Inc. Hydrated fat piece compositions and dough articles made therefrom
CA2745973A1 (en) * 2008-12-19 2010-06-24 Unilever Plc Edible fat powders
AU2009328392B2 (en) 2008-12-19 2013-08-22 Upfield Europe B.V. Edible fat powders
EA024216B1 (ru) 2010-06-22 2016-08-31 Юнилевер Н.В. Порошкообразные пищевые жиры
MX342040B (es) 2010-12-17 2016-09-12 Unilever Nv Emulsion de agua en aceite comestible.
MX337914B (es) 2010-12-17 2016-03-28 Unilever Nv Proceso para compactar polvo de grasa microporosa y polvo de grasa compactado asi obtenido.
EP2706863B1 (en) 2011-05-09 2017-10-04 General Mills, Inc. Fat compositions including shortening particles and shortening compositions without added non-interesterified hardstock fat, and related products
US9743681B2 (en) * 2011-05-17 2017-08-29 The Nisshin Oillio Group, Ltd. Oil and fat composition that can be used as non-tempering type hard butter
US9801392B2 (en) 2012-04-27 2017-10-31 General Mills, Inc. Fat particle compositions containing salt, dough and baked dough articles made therefrom, and related methods
EP2692238A1 (en) * 2012-08-03 2014-02-05 Bunge Növényolajipari Zártköruen Muködo Részvénytársasag New fat blend composition
WO2016149477A1 (en) 2015-03-18 2016-09-22 Cargill, Incorporated Low-fat water-in-oil emulsion
CN111378534B (zh) * 2018-12-27 2022-11-25 丰益(上海)生物技术研发中心有限公司 结构酯组合物及其制备方法
CA3206078A1 (en) * 2021-01-26 2022-08-04 Upfield Europe B.V. Structuring fats

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1107206A (en) * 1964-12-28 1968-03-27 Nat Biscuit Co Hard butter and chocolate coating composition containing same
DE3360419D1 (en) 1982-03-12 1985-08-29 Unilever Nv Margarine fat blend, and a process for producing said fat blend
GB8432058D0 (en) * 1984-12-19 1985-01-30 Unilever Plc Edible fat
EP0470658B1 (en) * 1990-08-02 1994-09-07 Unilever N.V. Improvements in edible fats
EP0530864B1 (en) 1991-07-03 1995-04-19 Unilever N.V. Improved chocolate compositions
US5470598A (en) * 1994-03-23 1995-11-28 The Procter & Gamble Company Beta-prime stable low-saturate, low trans, all purpose shortening
RU2110184C1 (ru) * 1997-06-13 1998-05-10 Мелкон Павлович Азнаурьян Маргарин
US6238926B1 (en) * 1997-09-17 2001-05-29 Cargilll, Incorporated Partial interesterification of triacylglycerols
GB2350618A (en) * 1999-06-01 2000-12-06 Danisco Shortening systems comprising a non-hydrogenated vegetable oil and either a stearine fraction or a saturated fatty acid diglyceride

Also Published As

Publication number Publication date
US7524524B2 (en) 2009-04-28
PL205287B1 (pl) 2010-03-31
AU2003218752A1 (en) 2003-10-20
RU2004132825A (ru) 2005-06-10
AU2003218752B2 (en) 2006-12-07
ATE457649T1 (de) 2010-03-15
PL371725A1 (en) 2005-06-27
US20050220965A1 (en) 2005-10-06
CA2481700A1 (en) 2003-10-16
BR0308747B1 (pt) 2013-12-17
EP1492410A1 (en) 2005-01-05
WO2003084337A1 (en) 2003-10-16
CA2481700C (en) 2012-10-09
EP1492410B1 (en) 2010-02-17
MXPA04009732A (es) 2005-01-11
RU2307517C2 (ru) 2007-10-10
DE60331298D1 (de) 2010-04-01
ZA200407149B (en) 2006-02-22

Similar Documents

Publication Publication Date Title
BR0308747A (pt) Gordura que compreende uma mistura de triglicerìdeos, processo apropriado para preparação da gordura de triglicerìdeo, processo de preparação de espalhante em emulsão de água em óleo comestìvel e espalhante
ATE551908T1 (de) Triglyceridfett
EA201000400A1 (ru) Твердые жировые композиции, содержащие полиненасыщенные жирные кислоты, и способы их получения и использования
DK1290119T3 (da) Fremstilling af en blanding af triglycerider
CO4650021A1 (es) Amalgama grasa para margarina y esparcidos w/o cual puede utilizarse como margarina y en esparcidos, la amalgama grasa y la grasa de margarina y el producto graso asi obtenidos
MY178510A (en) Plastic fat composition
DK1682226T3 (da) Lipidpræparat til forbedring af mineralabsorption
BRPI0416403A (pt) composição de óleo enriquecida em diglicerìdeo com ácido linoléico conjugado
RU2013142936A (ru) Шоколадный или шоколадоподобный материал и способ его получения
RU2137820C1 (ru) Пищевой антиоксидант
MXPA06000320A (es) Composicion oleosa o grasosa antioxidante que contiene acidos grasos altamente insaturados de cadena larga.
DE60336072D1 (de) Triglyzeridfett
AU643763B2 (en) Fats rich in behenic and stearic and/or palmitic acids
EA200201217A1 (ru) Состав для уменьшения гидравлического сопротивления
WO2004108871A3 (fr) Compositions liquides a base d'huile de colza oleique modifiee, utiles a titre de liquides isolants et caloporteurs, et dispositifs electriques les contenant
WO2007078311A3 (en) Non-hydrogenated vegetable oil based margarine
RU2004128937A (ru) Жир с высоким содержанием триглицеридов, пригодный для производства спредов
EP1965652A4 (en) REDUCTION BASED ON NON-HYDROGENIZED PLANT OIL BY USING AN INCREASED DIGLYCERIN EMULSIFIER COMPOSITION
IES940672A2 (en) "An edible fat blend"
CA2507994A1 (en) Oil in water emulsion
Mylostyvyi Improving the technology of oxidative stabilization of rapeseed oil
GB2427198A (en) Cooking oil containing camelina oil
BG109677A (bg) Етерични свещи с лечебен ефект
CA2457208A1 (en) Composite oil
DK200200324A (da) Fødemiddel med hensigtsmæssig sammensætning af fedtstofferne

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/12/2013, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved
B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 19A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2661 DE 04-01-2022 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.